Avoro Capital Advisors LLC Apellis Pharmaceuticals, Inc. Call Options Transaction History
Avoro Capital Advisors LLC
- $6.65 Billion
- Q3 2024
Call Options
2 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
113MCall Options Held
3.85MPut Options Held
1.09M-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$339 Million14.88% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$337 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$287 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$165 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.4MShares$126 Million4.68% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.13B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...